Clinical trial
A Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose, Dose-escalation Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP212525 in Healthy Volunteers
NCT06736587 is registered in ClinicalTrials.gov with Daewoong Pharmaceutical Co. LTD. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose, Dose-escalation Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP212525 in Healthy Volunteers
- Lead sponsor
- Daewoong Pharmaceutical Co. LTD.
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- December 10, 2024
- Completion date
- March 30, 2027
- Enrollment
- 84 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.